Related by context. All words. (Click for frequent words.) 68 Pivotal Phase III 68 Febuxostat 68 Degarelix 67 Glatiramer Acetate 67 Granted Orphan Drug 67 PDE4 inhibitor 67 Phase 2b Clinical Trial 67 Meets Primary Endpoint 67 Pazopanib 66 Multiple Ascending Dose 66 Mycophenolate Mofetil 66 Dasatinib 66 Posaconazole 66 MAGE A3 ASCI 66 ZACTIMA 66 Peginterferon Alfa 2a 66 Pemetrexed 66 Hydrochlorothiazide Tablets 66 HoFH 66 Ambrisentan 66 icatibant 66 Dyloject TM 66 Toremifene 66 Iloperidone 66 AEGR 66 CIMZIA TM 66 Archexin 66 NDA Submission 65 Orphan Designation 65 Investigational Compound 65 thalidomide Thalomid 65 Trobalt 65 Announces Tentative Approval 65 Prolongs Survival 65 Initiate Phase 65 Vidofludimus 65 Adjuvant Treatment 65 Submits NDA 65 Bosutinib 65 Dacogen decitabine 65 Xeloda ® 65 Initiates Phase III 65 Successfully Completes Phase 65 Soft Tissue Sarcoma 65 FDA Approvals 65 Temsirolimus 65 Qutenza TM 65 Glufosfamide 65 selective adenosine 65 Isavuconazole 65 Phase III Clinical Trial 65 Cimzia TM 65 Levoleucovorin 65 inhalation powder 65 Lenalidomide 65 Hormone Refractory Prostate Cancer 65 Roflumilast 65 Maribavir 65 prucalopride 65 Parathyroid Hormone 65 BRILINTA 65 RAPAFLO 65 Risperidone Oral Solution 65 Angiotensin Converting Enzyme 64 HYCAMTIN 64 Initiated Phase 64 Initiates Clinical 64 Drug Eluting Stent System 64 Zemplar Capsules 64 FDA Approvable Letter 64 Onrigin 64 Aflibercept 64 Luveniq 64 Orally administered 64 plasma kallikrein inhibitor 64 Saforis 64 Metformin HCl 64 BENICAR HCT 64 Sapacitabine 64 Tarceva TM 64 GW# [003] 64 TO AVOID PREGNANCY WHILE 64 IND Application 64 Kepivance 64 Panzem R NCD 64 DCCR 64 cinacalcet 64 Dose Ranging Study 64 Darusentan 64 Kamada AAT 64 Accelerated Approval 64 HCl Tablets 64 Firazyr 64 Pertuzumab 64 Resubmission 64 Amrubicin 64 histamine dihydrochloride 64 Melphalan 64 VISICOL R 64 relapsed MM 64 selective A2A adenosine receptor 64 HuMax 64 Ziprasidone 64 Teysuno 64 Ozarelix 64 YONDELIS 64 CYT# QbG# 64 topically administered 64 RhuDex ® 64 PREOS R 64 Orapred ODT 64 Prospective Randomized 64 Granulocyte Colony Stimulating Factor 64 adenosine injection 64 therefore therapeutically equivalent 64 TEMODAL 64 RhuDex 64 Treprostinil 64 ® lenalidomide 64 Trandolapril 64 Vidaza azacitidine 63 Omacetaxine 63 sorafenib Nexavar 63 receptor tyrosine kinase inhibitor 63 Receives Fast Track 63 biologic DMARD 63 Alvesco R 63 Pivotal Trial 63 platelet inhibitor 63 GlaxoSmithKline Requip 63 Targretin capsules 63 paclitaxel poliglumex 63 PrevOnco 63 Completes Patient Enrollment 63 oral renin inhibitor 63 Noxafil 63 Aeolus Pharmaceuticals Announces 63 rilonacept 63 novel oral anticoagulant 63 Hsp# Inhibitor 63 PEG IFN 63 ISTODAX 63 FDA Okays 63 Traficet EN 63 somatostatin analog 63 Initiate Clinical Trial 63 Alferon N 63 Lubiprostone 63 Confirmatory Phase 63 generation purine nucleoside 63 HDAC Inhibitor 63 Patient Enrollment 63 liposomal formulation 63 Decitabine 63 Etanercept 63 BAL# [002] 63 vinorelbine tartrate 63 SYCREST 63 terlipressin 63 NeuVax 63 beta 1a 63 Pegylated Liposomal Doxorubicin 63 Fenofibrate 63 Acute Decompensated Heart Failure 63 Files Investigational 63 ZOLINZA 63 Epratuzumab 63 Arranon 63 Aurora Kinase 63 Silodosin 63 LAB CGRP 63 REMINYL ® 63 Tesmilifene 63 Gamunex C 63 ADP receptor antagonist 63 ZYBRESTAT TM 63 metastatic malignant 63 Investigational Treatment 63 Initiates Enrollment 63 Emezine 63 Cancidas 63 FOR FURTHER INFORMATION ABOUT 63 Telatinib 63 Receptor Agonist 63 JAK Inhibitor 63 LymphoStat B belimumab 63 Tiotropium 63 Fast Track Status 63 Eltrombopag 63 diclofenac sodium 63 Hydrochlorothiazide 63 Receives Orphan Drug Designation 63 Q#IR 63 ACTEMRA TM 63 Receptor Antagonists 63 Simulect 63 HuMax EGFr 63 miconazole Lauriad ® 63 BENICAR 63 ULORIC 63 Pivotal Phase 63 pharmacokinetic PK study 63 vapreotide acetate 63 Elitek 63 MVax 63 docetaxel Taxotere ® 63 HCl Injection 62 COLAZAL R 62 Acute Ischemic Stroke 62 Vandetanib 62 ACUROX ® 62 EOquin TM 62 Immunomodulatory 62 Lung Cancer Drug 62 CIMZIA R 62 olmesartan medoxomil hydrochlorothiazide 62 fosbretabulin 62 Ganciclovir 62 Protease Inhibitor 62 Avanafil 62 brivaracetam 62 Evoltra 62 Aclidinium 62 AGHD 62 Randomized Phase 62 Inhalation Aerosol 62 azilsartan medoxomil 62 Ticagrelor 62 Novel Inhibitor 62 xanthine oxidase inhibitor 62 Icatibant 62 Zenpep 62 ATL/TV# 62 Interferon alfa 62 Psoriasis Drug 62 Glatiramer acetate 62 Cilostazol 62 CIMZIA ™ 62 Oral Insulin 62 Yondelis ® 62 Bortezomib 62 Sevelamer 62 Fluconazole 62 PROMACTA 62 Tumor Necrosis Factor 62 Interferon Alfa 62 Aciphex R 62 highly selective inhibitor 62 Antitumor Activity 62 Teva Provides Update 62 balsalazide tablet 62 Hycamtin ® 62 Recombinant Human 62 Velcade bortezomib 62 ara C 62 MP4OX 62 topical gel formulation 62 SYN# 62 successfully commercialize Iluvien 62 Commences Phase 62 Protease Inhibitors 62 Suppositories 62 Pralatrexate 62 pain palliation 62 Complete Response 62 sitaxsentan 62 Anti Tumor 62 multikinase inhibitor 62 Indomethacin 62 Expedited Review 62 Bendamustine 62 Frova ® 62 Safinamide 62 Files IND 62 Thrombin 62 Testosterone Gel 62 Fondaparinux 62 Demonstrates Significant 62 Taclonex R 62 Anti Tumor Activity 62 baminercept 62 Neurodex 62 sodium glucose cotransporter 62 HCl capsules 62 Xanafide 62 Oral Spray 62 Bazedoxifene 62 Trabectedin 62 Argatroban 62 mg Tablets 62 Esbriet pirfenidone 62 ACE Inhibitors 62 Mg Uk 62 Enzyme Replacement Therapy 62 DUROS 62 Zidovudine Tablets 62 Chemoradiation 62 FDA Accepts 62 Formoterol 62 gemcitabine cisplatin 62 sunitinib malate 62 OZURDEX 62 Severe Sepsis 62 Lenocta 62 Betaferon R 62 Pharmacokinetics PK 62 Nilotinib 62 PDUFA Date 62 Synerx Pharma 62 Advanced Melanoma 62 PEGylated interferon 62 Mipomersen 62 Fluorouracil 62 FDA APPROVES 62 Crofelemer budesonide foam 62 galiximab 62 Triapine R 62 PANVAC VF 62 GSK# [001] 62 Azacitidine 62 Vascugel 62 Carfilzomib 62 orally inhaled 62 Gemzar gemcitabine 62 Muraglitazar 62 Deforolimus 62 SAR# [002] 62 SUTENT ® 62 inhaled AAT 62 Ranolazine 62 wilate ® 62 Plaque Psoriasis 62 intravesical infusion therapy 62 Phase III Clinical Trials 62 UPLYSO 62 Prostate Cancer Vaccine 62 Tamsulosin 62 Plicera 62 Receives Approvable Letter 62 intravenous recombinant 62 Radioimmunotherapy 62 Phase III HEAT 62 5 lipoxygenase inhibitor 61 biliary tract cancer 61 miconazole Lauriad R 61 Generic Version 61 Metastatic Melanoma 61 Humira adalimumab 61 Oral Fingolimod 61 Estrogen Receptor 61 Angiox ® 61 PROMACTA ® 61 Shows Efficacy 61 reslizumab 61 Virulizin ® 61 AZILECT ® 61 Phase Ib II 61 Levetiracetam 61 HBeAg + 61 capsules USP 61 oxypurinol 61 Aliskiren 61 teriflunomide 61 Clinical Study Shows 61 Anturol TM 61 Vascular Disrupting Agent 61 CCX# 61 sargramostim 61 regorafenib 61 Nipent R 61 Receives Orphan Drug 61 Aptivus ® 61 Medoxomil 61 ALN HPN 61 treat chronic sinusitis 61 Orally Active 61 Pregabalin 61 Receives Marketing Authorization 61 CYT# potent vascular disrupting 61 BENLYSTA ® 61 octreotide implant 61 novel histone deacetylase 61 Investigational Drug 61 PSMA ADC 61 Aplidin 61 LibiGel ® 61 Zenvia Phase III 61 intranasal formulation 61 Onconase 61 Mylan Receives Approval 61 Topical Gel 61 Xelox 61 Boceprevir 61 Rigel R# 61 Vernakalant 61 Initiates Clinical Trial 61 Launches Generic Version 61 pharmacokinetic PK profile 61 orphan designation 61 TREDAPTIVE 61 Vaprisol 61 Delayed Release Tablets 61 IgG1 monoclonal antibody 61 secondary hyperparathyroidism 61 topoisomerase II inhibitor 61 Is Well Tolerated 61 Pivotal Phase II 61 injectable diclofenac 61 orally administered inhibitor 61 Tanespimycin 61 Elagolix 61 Gastrointestinal Stromal Tumors 61 Levofloxacin 61 Natalizumab 61 PREOS 61 Lupus Drug 61 YERVOY 61 dihydrochloride 61 Mg Usa 61 Gemcitabine 61 Perforomist ™ Inhalation Solution 61 synthetic peptide containing 61 huN# DM1 61 Zegerid OTC 61 RezularTM 61 PHX# 61 Pyridorin 61 tocilizumab 61 Vinorelbine 61 phase IIIb 61 FIRAZYR 61 depsipeptide 61 Bayer Onyx 61 SIR Spheres 61 SPRIX ® 61 Belerofon 61 CAPHOSOL 61 Taxol ® 61 Cardiotoxicity 61 Stage IIB 61 fluoropyrimidine 61 Pharmacokinetic studies 61 tubulin inhibitor 61 Torisel 61 Presents Positive 61 corticosteroid dexamethasone 61 Monoclonal antibody 61 Ropinirole 61 LUCASSIN 61 MetroGel 61 HCV Protease Inhibitor 61 Phase 1b clinical trials 61 autologous cellular immunotherapy 61 urocortin 2 61 Receives Positive Opinion 61 Ciclesonide 61 HuMax CD4 61 pioglitazone HCl 61 TM Everolimus Eluting 61 Clinical Trial Evaluating 61 Increlex R 61 MYCAMINE 61 Dabigatran etexilate 61 Pharmacokinetic Study 61 refractory chronic lymphocytic 61 Initiates Phase 2b 61 EDEMA3 61 Long Term Efficacy 61 1mg 2mg 61 Combunox 61 Nebivolol 61 IONSYS TM 61 efaproxiral 61 Vfend 61 Cutaneous T 61 Fludara ® 61 5 HT3 antagonist 61 fluvastatin 61 oral ridaforolimus 61 omacetaxine mepesuccinate 61 MKC# 61 ACE Inhibitor 61 Carbidopa Levodopa 61 randomized controlled Phase 61 Bezielle 61 serotonin norepinephrine reuptake inhibitor 61 CardioVascular BioTherapeutics 61 TRO# 61 targeted antifolate 61 Interferon beta 1b 61 Phase III Trial 61 Recurrent Glioblastoma 61 UCB Keppra 61 #mg/#mg 61 glycoprotein GP IIb IIIa 61 bile acid sequestrant 61 Expanded Indication 61 LT NS# 61 Cloretazine 61 Improved Survival 61 novel emulsion formulation 61 Microwave Ablation System 61 Somatuline R Autogel R 61 E1 INT TM 61 Transdermal Patch 61 ularitide 61 Teriflunomide 61 ACOMPLIA R 61 Percutaneous Tibial Nerve Stimulation 61 Hydrochloride Injection 61 Moxifloxacin 60 Ceflatonin R 60 LymphoStat B TM 60 colesevelam HCl 60 Certican 60 RhuDex R 60 severe gastroparesis 60 mesylate 60 Namenda XR 60 including eniluracil ADH 60 Interferon Gamma 60 KSP inhibitor 60 Alkeran 60 Androgel R 60 chronic idiopathic thrombocytopenic purpura 60 dosing cohort 60 Castration Resistant Prostate Cancer 60 Double Blind Randomized 60 Terbinafine 60 Tablet Formulation 60 Urocortin 2 60 vidofludimus 60 Adjuvant Chemotherapy 60 Hexvix ® 60 Marqibo TM 60 Marketing Authorisation Application 60 OvaRex R 60 Orphan Status 60 Orphan Drug designations 60 Vildagliptin 60 Vitaxin 60 interferon beta 1b 60 BUPHENYL R sodium phenylbutyrate 60 G#DT 60 phase IIa clinical 60 chimeric monoclonal antibody 60 Zyclara 60 Generic Version Of 60 gefitinib Iressa 60 PEGylated interferon beta 1a 60 adalimumab Humira 60 Liprotamase 60 PRTX 60 Tartrate 60 docetaxel Taxotere R 60 Pivotal Study 60 Olmesartan 60 Genzyme Synvisc 60 Exelixis XL# 60 patientswith 60 Schizophrenia Treatment 60 Fabry Disease 60 BN# [004] 60 Thelin TM 60 FDA Orphan Drug 60 Myelodysplastic Syndrome MDS 60 CRMD# 60 Arixtra ® 60 Preotact 60 Irinotecan 60 nucleoside analog 60 MoxDuo IR 60 DR Tablets 60 Present Preclinical Data 60 Diabetic Foot Ulcer 60 Pulmonary Arterial Hypertension 60 liver resection surgeries 60 Kahalalide F 60 elotuzumab 60 STRIDE PD 60 Bayer HealthCare Onyx Pharmaceuticals 60 acting muscarinic antagonist 60 Mometasone Furoate 60 VAPRISOL 60 Brain Metastases 60 PDE4 60 Lamotrigine 60 Hepatitis C Genotype 60 Zirgan 60 Achieves Primary Endpoint 60 monoclonal antibody conjugated 60 treatment naive genotype 60 Improves Survival 60 microtubule inhibitor 60 Personalized Immunotherapy 60 haematologic 60 pan HDAC inhibitor 60 Platinol ® 60 pancreatic enzyme replacement 60 Carotid Artery Stenting 60 Relapsed Multiple Myeloma 60 tenofovir disoproxil fumarate Viread 60 Indacaterol 60 Generic Lovenox 60 topical ophthalmic 60 gemcitabine carboplatin 60 somatostatin analogues 60 atacicept 60 Tipranavir 60 Approvable 60 Catena ® 60 Amlodipine Besylate 60 Pivotal Clinical Trial 60 Tacrolimus 60 R lenalidomide 60 Hypertriglyceridemia 60 HQK 60 histone deacetylase HDAC inhibitor 60 humanized monoclonal 60 fenofibric acid 60 Milestone Payment From 60 Teflaro 60 pomalidomide 60 Zybrestat 60 dalbavancin 60 selective serotonin 2C receptor 60 ruxolitinib 60 Benlysta belimumab 60 Ixempra 60 Generic Versions 60 Antitumor 60 Orphan Drug status 60 reduce serum phosphate 60 CONBRIZA 60 BEXXAR 60 Metricath Gemini 60 Ereska 60 Study Evaluating 60 Submits Biologics License Application 60 Patients Treated With 60 ritonavir boosted 60 Drug Fails 60 Lung Cancer Trial 60 Venlafaxine 60 Intrathecal 60 Omnitarg 60 Abbokinase 60 Escitalopram 60 conjugated estrogens 60 LANTUS ® 60 Anavex #-# 60 PRIALT 60 PROCTOCORT R 60 Shows Promise Against 60 INSPIRE Trial Phase III 60 Daclizumab 60 ULTRASE 60 CIP TRAMADOL ER 60 long acting muscarinic 60 selective orally bioavailable 60 MYLOTARG 60 Tigecycline 60 controlled multicenter Phase 60 Oral Solution 60 Orphan Drug Status 60 Taro Receives 60 Denufosol 60 Cholinesterase Inhibitors 60 abacavir Ziagen 60 XYOTAX TM 60 Combo Therapy 60 Calcium Acetate 60 Inhaled Insulin 60 pregabalin Lyrica 60 Gout Drug 60 Anticancer Agent 60 MEVACOR 60 novel prodrug 60 Rheumatoid Arthritis Patients 60 Nasal Spray 60 Aloxi injection 60 Pivotal Trials 60 Technosphere ® 60 Topiramate Tablets 60 Cellegesic 60 Receives CE Marking 60 GTC recombinant form 60 selective estrogen receptor modulator 60 Tenormin 60 Relapsing Remitting Multiple Sclerosis 60 Presents Preclinical Data 60 Capesaris 60 HuMax CD# 60 neratinib 60 BLP# Liposome Vaccine 60 Demonstrates Efficacy 60 Fingolimod 60 ibritumomab tiuxetan 60 Bicalutamide 60 Janus kinase 60 dimeglumine 60 Belimumab 60 etanercept Enbrel 60 Sustained Release 60 GLASSIA 60 Renvela ® 60 Boniva ibandronate 60 gemcitabine Gemzar ® 60 Alexion Soliris 60 5alpha reductase 60 Capecitabine 60 Antiepileptic Drug 60 ™ Everolimus Eluting 60 Toctino ® alitretinoin 60 mineralocorticoid receptor 60 Aztreonam Lysine 60 lexidronam injection 60 Luteinizing Hormone Releasing Hormone 60 pharmacodynamic PD 60 Endeavor DES 60 PSN# [001] 60 Fulvestrant 60 Oracea R 60 olmesartan 60 Improves Outcomes 60 Inhaled Corticosteroids 60 Tyrima 60 Esomeprazole 60 COPAXONE R 60 CCX# B 60 DEB# 60 vemurafenib 60 Replacement Therapy 60 Vectibix panitumumab 60 dual endothelin receptor antagonist 60 vorinostat 60 Unresectable 60 granted Ortec 60 nimodipine 60 oncolytic vaccine 60 Eszopiclone 60 RELOVAIR ™ 60 Adverse Event 60 Advanced Renal Cell 59 TM Drug Eluting 59 JAK inhibitor 59 Dendreon Provenge 59 Metastatic Renal Cell Carcinoma 59 diarrhea predominant irritable 59 Pravachol pravastatin 59 Blinatumomab 59 Brinavess 59 Myocet 59 Tiazac 59 AZOR 59 Zenvia ™ 59 Daptomycin 59 Pliaglis 59 DORIBAX 59 #F ML 59 First Patient Dosed 59 CRp 59 Ondansetron Orally Disintegrating Tablets 59 schizophrenia CIAS 59 GATTEX TM 59 Oglemilast 59 ONGLYZA ™ 59 lumiliximab 59 Smooth Muscle 59 TLR antagonist 59 Hepatotoxicity 59 CTAP# Capsules 59 piperacillin tazobactam 59 CAELYX 59 R Saizen R 59 Ibritumomab Tiuxetan 59 AVONEX ® 59 MoxDuo 59 thromboxane A2 59 cathepsin K inhibitor 59 dutogliptin 59 Novel Compound 59 Randomized Clinical Trial 59 Factor VIIa 59 Phase IIA 59 sublingual tablets 59 Celgene Revlimid 59 ALVESCO R 59 Spiegelmer ® 59 Hypercholesterolemia 59 XIENCE V Everolimus Eluting 59 Glycopyrrolate 59 Cysteamine 59 Submits Investigational 59 Allovectin 7 ® 59 IIIb 59 Epidermal Growth Factor Receptor 59 receptor blocker 59 ONCONASE R 59 proteasome inhibitor 59 BioDelivery Sciences Announces 59 Release Tablets 59 TYGACIL 59 II Clinical Trial 59 Ixabepilone 59 Non inferiority 59 oxybutynin gel 59 hydrochloride capsules 59 Recommends Approval 59 Blood Pressure Drug 59 Vorinostat 59 clevidipine 59 Capsules USP 59 Zemplar 59 muscarinic antagonist 59 Tyrosine Kinase Inhibitor 59 BrachySil TM 59 Bivalirudin 59 IV Busulfex 59 casopitant 59 CLARITY study 59 liposomal doxorubicin 59 DU #b 59 Pafuramidine 59 assessing T DM1 59 OMNARIS 59 Tyrosine Kinase Inhibitors 59 PARP Inhibitor 59 receptor antagonism 59 Cand5 59 Squalamine 59 cromolyn sodium 59 Cethromycin 59 Non Responders 59 FDA Clearance 59 DNA methyltransferase inhibitors 59 Phase Ib study 59 Eraxis 59 Non Alcoholic Steatohepatitis 59 cortisol synthesis 59 Felodipine 59 Cardio Vascu Grow 59 Cleviprex TM clevidipine 59 ATACAND 59 Demonstrates Potential 59 Systemic Sclerosis 59 dasatinib Sprycel 59 phase IIb trial 59 MKC# MT 59 See CLINICAL PHARMACOLOGY 59 azacytidine 59 Bucindolol 59 vinca alkaloid 59 fluticasone salmeterol 59 Mimpara 59 LAS# [002] 59 Anticancer Drug 59 Osteoporosis Drug 59 Marketing Authorisation 59 Survival Benefit 59 EOquin 59 Randomized Evaluation 59 IND Filing 59 torezolid phosphate 59 MOVIPREP R 59 PROSTVAC ® 59 5 Fluorouracil 59 glatiramer 59 UCB Cimzia 59 Huntexil 59 synthetic siRNA 59 Asthma COPD 59 ART# 59 humanised monoclonal antibody 59 Milestone Payments 59 completely resected 59 Grants Orphan Drug 59 Privigen 59 aspirin clopidogrel 59 Migraine Drug 59 glatiramer acetate 59 Adalimumab 59 inhalation aerosol 59 Ridaforolimus 59 IFN α 59 CoFactor 59 Arikace 59 Pradaxa ® 59 renin inhibitor 59 Multaq R 59 Bafetinib 59 recurrent glioblastoma multiforme 59 Alemtuzumab 59 Aptamer 59 Urocidin 59 BLA filing 59 irbesartan 59 Desvenlafaxine Succinate 59 demonstrated antitumor activity 59 Topline Results 59 pioglitazone hydrochloride 59 Adjuvant Therapy 59 Cyclophosphamide 59 IIa trials 59 trospium 59 Receives Tentative FDA 59 uricase 59 EGFR HER2 59 Presents Positive Preclinical 59 ThermoDox R 59 hydrochloride tablets 59 warfarin sodium 59 VANOS TM 59 beta lactamase inhibitor 59 bortezomib Velcade R 59 eltrombopag 59 LUMINATE 59 Synera 59 SinuNase 59 Schizophrenia Drug 59 Nabi HB Intravenous 59 NAVISTAR R 59 Shows Statistically Significant 59 Extended Release tablets 59 Roche Actemra 59 Atrasentan 59 Certolizumab pegol 59 BioNumerik 59 Bevacizumab 59 erlotinib Tarceva ® 59 Fibrillex TM 59 Emselex 59 Evoltra ® 59 efalizumab 59 ELACYT 59 Ceflatonin 59 Prolastin 59 OMP designation 59 Cethrin 59 Dose Ranging 59 HepaSphere 59 OncoGel 59 Pramlintide 59 Acute Coronary Syndromes ACS 59 PrevOnco ™ 59 Confirms Efficacy 59 Solaraze R 59 Proxinium TM 59 Danazol 59 VitiGam TM 59 Glucophage XR 59 RECOTHROM R 59 6R BH4 59 TAXOTERE R 59 Xcytrin R 59 CINQUIL 59 Intravitreal 59 DNA demethylating agent 59 Januvia sitagliptin 59 antibody MAb 59 PYY #-# 59 Acute Heart Failure 59 Randomized Phase II 59 SuperAntibody 59 malignant ascites 59 Dementia Related Psychosis 59 Platinol ® cisplatin 59 Phosphodiesterase 59 EBMT criteria 59 Fibrinogen 59 SomatoKine 59 MTP inhibitor 59 esophageal candidiasis 59 eprotirome 59 include Phenoptin TM 59 Anticoagulant 59 Submits Response 59 Carvedilol 59 tipifarnib 59 PGL# 59 LEVADEX ™ 59 OvaRex MAb 59 GHRH 59 Allergic Rhinitis 59 Medidur ™ FA 59 selective agonist 59 MYOBLOC 59 CHMP Opinion 59 Vimpat lacosamide 59 Tablets #mg [001] 59 selective antagonist 59 #mg #mg #mg #mg [002] 59 BRIM2 59 PF # [002] 59 Treating Chronic 59 Zaleplon 59 NasalFent 59 Sanvar 59 Premarket Approval